ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,356Medicare Part D Prescriptions Filled, Including Refills

Rank: 359 out of 1456

$605K Total Retail Price of All Prescriptions

Rank: 335 out of 1456

233 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 233 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

22% of this provider’s 233 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,284 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 373 358 1 1
WARFARIN SODIUM 366 366 2 21
LISINOPRIL 297 275 3 3
DONEPEZIL HCL 268 267 4 29
LEVOTHYROXINE SODIUM 259 240 5 4
NAMENDA 253 253 6 38
HYDROCODONE-ACETAMINOPHEN 248 229 S3 7 6
FUROSEMIDE 247 236 8 7
OXYCODONE-ACETAMINOPHEN 230 215 S2 9 109
MIRTAZAPINE 217 186 10 65
NOVOLOG 213 187 11 104
TRAZODONE HCL 184 165 12 47
PRAVASTATIN SODIUM 180 161 13 9
SIMVASTATIN 169 154 14 2
GABAPENTIN 169 135 14 13
LANTUS 165 134 16 50
METOPROLOL TARTRATE 161 149 17 12
QUETIAPINE FUMARATE 145 133 18 78
CARVEDILOL 140 126 19 20
DIVALPROEX SODIUM 137 133 20 108
ALBUTEROL SULFATE 136 114 21 136
CYMBALTA 136 122 21 52
SERTRALINE HCL 136 129 21 25
TRAMADOL HCL 133 131 24 17
CLOPIDOGREL 119 104 25 32
ESCITALOPRAM OXALATE 117 112 26 74
RISPERIDONE 117 101 26 72
EXELON 110 110 28 105
PANTOPRAZOLE SODIUM 106 95 29 43
CITALOPRAM HBR 103 77 30 22
POTASSIUM CHLORIDE 99 69 31 15
KLOR-CON M10 99 99 31 140
ZOLPIDEM TARTRATE 97 82 33 14
ISOSORBIDE MONONITRATE ER 93 86 34 60
METOPROLOL SUCCINATE 87 70 35 19
ATORVASTATIN CALCIUM 84 84 36 11
LEVETIRACETAM 82 55 37 97
DOXYCYCLINE HYCLATE 76 58 38 129
TAMSULOSIN HCL 74 67 39 34
LACTULOSE 73 48 40 192
HYDRALAZINE HCL 72 70 41 48
FENTANYL 70 63 S2 42 114
LEVOFLOXACIN 67 64 43 79
LIDODERM 66 46 44 166
DIGOXIN 64 54 45 62
HUMALOG 64 60 45 196
LYRICA 60 59 47 91
PLAVIX 60 56 47 46
CEFTRIAXONE 60 53 47 263
AMOX TR-POTASSIUM CLAVULANATE 53 51 50 118
FLUTICASONE PROPIONATE 51 47 51 28
OLANZAPINE 50 37 52 183
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.